Understanding Drug Development For Rare Diseases A Community Conversation
Exploring Drug Development For Rare Diseases A Community Conversation reveals several interesting facts. You are invited to a
Key Takeaways about Drug Development For Rare Diseases A Community Conversation
- FDA will host
- The purpose of the video is to inform patients, patient advocates, caregivers, scientists and others who have an interest in
- C-Path Director of Data Science Ramona Walls talks about the importance of data sharing in
- Dr. Emily Morris, mathematical statistician at FDA's Center for
- Nick Kenny, PhD, Chief Scientific Officer at Syntheos Health, understands the important role patients play in
Detailed Analysis of Drug Development For Rare Diseases A Community Conversation
... Rare and C-Path's Rare & Despite increasing numbers of drug targets and technologies,
Davelyn Hood, MD, Joshua Mann, MPH, and Jessica Bohonowych, Ph.D. discuss what
Stay tuned for more updates related to Drug Development For Rare Diseases A Community Conversation.